FDA grants Fast Track Designation for azenosertib in Cyclin E1 positive cancer. Clinical data update to follow on January 29, 2025. Zentalis Pharmaceuticals announced that the U.S. FDA has granted ...
In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...
Zentalis Pharmaceuticals has won a U.S. Food and Drug Administration fast-track designation for its lead product candidate azenosertib for certain cancer patients with high levels of the Cyclin E1 ...
All rights reserved. Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP. A Charity, Not for Profit. Company Limited by Guarantee. Registered in England No.
Stock analysts at StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “buy” rating on ...
Kronos Bio (NASDAQ:KRON – Get Free Report) and Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two ...
A research team has successfully utilized human respiratory organoids (mini-organs) to propagate human rhinovirus C (HRV-C), which had previously been refractory to conventional virus cultivation ...